Kao, S.C-H.
3220  Ergebnisse:
Personensuche X
?
2

126P AdvanTIG-105: Phase Ib dose-expansion study of ociperl..:

Frentzas, S. ; Meniawy, T. ; Kao, S.C-H....
Immuno-Oncology and Technology.  16 (2022)  - p. 100238 , 2022
 
?
3

148P AdvanTIG-105: Phase Ib dose-expansion study of ociperl..:

Zhang, J. ; Hussein, M. ; Kao, S.C-H....
Immuno-Oncology and Technology.  16 (2022)  - p. 100260 , 2022
 
?
4

Comment on 'Existing prognostic models, but not neutrophil-..:

Kao, S C-H ; van Zandwijk, N ; Clarke, S
British Journal of Cancer.  111 (2014)  12 - p. 2376-2376 , 2014
 
?
5

Second‐line therapy for castrate‐resistant prostate cancer:..:

KAO, S C‐H ; HOVEY, E ; MARX, G
Asia-Pacific Journal of Clinical Oncology.  7 (2011)  3 - p. 212-223 , 2011
 
?
7

Association Between Statin Use and Exacerbation of Chronic ..:

Huang YJ ; Kao S ; Kao LT...
https://www.dovepress.com/association-between-statin-use-and-exacerbation-of-chronic-obstructive-peer-reviewed-article-COPD.  , 2021
 
?
8

Contemporary Irish theatre 

transnational practices  Dramaturgies ; Vol. 35
Kao, Wei-Hung , [2015]
Exemplar:  Zentrale:E03 a ang 657.5/526
 
?
9

Adjusted estimate of the prevalence of hepatitis delta viru..:

Razavi-Shearer, D ; Child, H ; Razavi-Shearer, K...
https://discovery.ucl.ac.uk/id/eprint/10185791/1/1-s2.0-S0168827823052856-main.pdf.  , 2023
 
1-15